Detalles de la búsqueda
1.
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.
J Neurol Neurosurg Psychiatry
; 95(2): 134-141, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558400
2.
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study.
J Neurol Neurosurg Psychiatry
; 95(2): 125-133, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37748927
3.
Prominent epigenetic and transcriptomic changes in CD4+ and CD8+ T cells during and after pregnancy in women with multiple sclerosis and controls.
J Neuroinflammation
; 20(1): 98, 2023 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37106402
4.
Morbidity and mortality among children, adolescents, and young adults with cancer over six decades: a Swedish population-based cohort study (the Rebuc study).
Lancet Reg Health Eur
; 42: 100925, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38800108
5.
Dimethyl fumarate treatment in relapsing remitting MS changes the inflammatory CSF protein profile by a prominent decrease in T-helper 1 immunity.
Mult Scler Relat Disord
; 80: 105126, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952502
6.
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort.
Mult Scler Relat Disord
; 70: 104481, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36603296
7.
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis.
Nat Commun
; 14(1): 6903, 2023 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37903821
8.
Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy.
Front Immunol
; 13: 930947, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35967338
9.
RNA-sequencing and mass-spectrometry proteomic time-series analysis of T-cell differentiation identified multiple splice variants models that predicted validated protein biomarkers in inflammatory diseases.
Front Mol Biosci
; 9: 916128, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36106020
10.
COVID-19 clinical outcomes and DMT of MS patients and population-based controls.
Ann Clin Transl Neurol
; 9(9): 1449-1458, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35993445
11.
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial.
Lancet Neurol
; 21(8): 693-703, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35841908
12.
Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets.
PLoS One
; 15(2): e0228380, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32012202
13.
Non-Bacterial Thrombotic Endocarditis: A Presentation of COVID-19.
Eur J Case Rep Intern Med
; 7(8): 001811, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32789144
14.
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
Sci Transl Med
; 7(313): 313ra178, 2015 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26560356
15.
Short- and long-term effects of T-cell modulating agents in experimental autoimmunity.
Toxicology
; 196(3): 197-209, 2004 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15036746
16.
Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
PLoS One
; 8(12): e81685, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24312575
17.
Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis.
PLoS One
; 7(9): e44739, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23028598
Resultados
1 -
17
de 17
1
Próxima >
>>